Evidence map›Paper›PMID 25609670›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

VH replacement in primary immunoglobulin repertoire diversification.

Amy Sun, Tatiana I Novobrantseva, Maryaline Coffre, Susannah L Hewitt, Kari Jensen, Jane A Skok, Klaus Rajewsky, Sergei B Koralov

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Mechanisms of central tolerance for B cells.Nature reviews. Immunology · 2017
    Review
  10. Article
  11. Article
  12. Heavy-chain receptor editing unbound.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  13. Antibody repertoire diversification through VH gene replacement in mice cloned from an IgA plasma cell.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Amy SunDepartment of Pathology, New York University School of Medicine, New York, NY 10016; and.
Tatiana I NovobrantsevaImmune Disease Institute, Boston, MA 02115.
Maryaline CoffreDepartment of Pathology, New York University School of Medicine, New York, NY 10016; and.
Susannah L HewittDepartment of Pathology, New York University School of Medicine, New York, NY 10016; and.
Kari JensenImmune Disease Institute, Boston, MA 02115.
Jane A SkokDepartment of Pathology, New York University School of Medicine, New York, NY 10016; and.
Klaus RajewskyImmune Disease Institute, Boston, MA 02115.
Sergei B KoralovDepartment of Pathology, New York University School of Medicine, New York, NY 10016; and sergei.koralov@nyumc.org.

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
MEDICAL SCIENTIST TRAININGT32GM007308 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PHILIPS, MARK REID · 1985 to 2019
$23.2M
TRAINING PROGRAM IN MOLECULAR ONCOLOGY &IMMUNOLOGYT32CA009161 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CARROLL, WILLIAM L., LEVY, DAVID E · 1985 to 2020
$13.3M
Enhancer Driven Gene Regulation During Lymphocyte DevelopmentR01GM112192 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SKOK, JANE AMANDA · 2014 to 2016
$1.6M
Non-coding RNAs in B lymphocyte development and functionR21AI110830 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI KORALOV, SERGEI BORISOVICH · 2014 to 2014
$170k
NCI NIH HHS 5T32CA009161-39NCI NIH HHS P30 CA016087NCI NIH HHS T32 CA009161NIAID NIH HHS R21 AI110830NIAID NIH HHS R21AI110830NIGMS NIH HHS 5T32GM007308-36NIGMS NIH HHS R01 GM112192NIGMS NIH HHS T32 GM007308
6 · The paper itself

Abstract

The genes encoding the variable (V) region of the B-cell antigen receptor (BCR) are assembled from V, D (diversity), and J (joining) elements through a RAG-mediated recombination process that relies on the recognition of recombination signal sequences (RSSs) flanking the individual elements. Secondary V(D)J rearrangement modifies the original Ig rearrangement if a nonproductive original joint is formed, as a response to inappropriate signaling from a self-reactive BCR, or as part of a stochastic mechanism to further diversify the Ig repertoire. VH replacement represents a RAG-mediated secondary rearrangement in which an upstream VH element recombines with a rearranged VHDHJH joint to generate a new BCR specificity. The rearrangement occurs between the cryptic RSS of the original VH element and the conventional RSS of the invading VH gene, leaving behind a footprint of up to five base pairs (bps) of the original VH gene that is often further obscured by exonuclease activity and N-nucleotide addition. We have previously demonstrated that VH replacement can efficiently rescue the development of B cells that have acquired two nonproductive heavy chain (IgH) rearrangements. Here we describe a novel knock-in mouse model in which the prerearranged IgH locus resembles an endogenously rearranged productive VHDHJH allele. Using this mouse model, we characterized the role of VH replacement in the diversification of the primary Ig repertoire through the modification of productive VHDHJH rearrangements. Our results indicate that VH replacement occurs before Ig light chain rearrangement and thus is not involved in the editing of self-reactive antibodies.

Indexed as

AnimalsB-LymphocytesCell CompartmentationImmunoglobulin Variable RegionMiceMice, TransgenicStochastic ProcessesImmunoglobulin Variable Regionlymphocyte developmentreceptor editingsecondary rearrangementV(D)JVH replacement

Identifiers

PMID25609670
PMCPMC4321307

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.